Exocrine Pancreatic Insufficiency Market Finds Opportunity in Growing Number of Cystic Fibrosis Patients
Exocrine pancreatic insufficiency is a serious medical condition in which a patient is unable to fully process ingested food. This happens due to the inability of the pancreas to create the necessary amounts of digestive enzymes. Exocrine pancreatic insufficiency, or EPI, is very common among dogs, but is growing in prevalence among humans as well. It is usually a case found in humans that are already suffering from the Shwachman-Diamond Syndrome, or more commonly, cystic fibrosis.
View full press release